Communiqués HTG Molecular Diagnostics, Inc.

Actions

HTGMQ

US40434H3021

Equipement et technologie médicale avancés

Marché Fermé - OTC Markets 21:03:16 20/08/2026			Varia. 5j.	Varia. 1 janv.
0,000100 ^USD	+9 900,00%		0,00%	-

21/05/25	Rejet de la demande de conversion de la procédure de HTG Molecular Diagnostics, Inc.	CI
28/04/25	Requête en conversion de dossier déposée par HTG Molecular Diagnostics, Inc.	CI

Communiqués

08/06/23	HTG MOLECULAR DIAGNOSTICS, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
18/05/23	HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention	AQ
16/05/23	HTG Highlights the Advantages of Its Drug Discovery Engine	AQ
11/05/23	HTG Molecular Diagnostics : Reports First Quarter 2023 Results and Provides Recent Business Highlights - Form 8-K	PU
10/05/23	HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights	AQ
25/04/23	HTG MOLECULAR DIAGNOSTICS, INC : Other Events (form 8-K)	AQ
25/04/23	HTG Provides Update on Drug Discovery Partnering Initiative	AQ
18/04/23	HTG Announces Key First Quarter Milestone Achievements for Drug Discovery	AQ
06/04/23	HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19	AQ
30/03/23	HTG MOLECULAR DIAGNOSTICS, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
03/02/23	HTG MOLECULAR DIAGNOSTICS, INC : Change in Directors or Principal Officers (form 8-K)	AQ
09/01/23	HTG Provides a Year-End Update on its Drug Discovery Business and Attends LifeSci Partners 2023 Corporate Access Event	AQ
06/01/23	HTG Announces Certain Preliminary 2022 Unaudited Financial Results	AQ
29/12/22	HTG MOLECULAR DIAGNOSTICS, INC : Other Events (form 8-K)	AQ
28/12/22	HTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery KOL Webcast Series	AQ
23/12/22	HTG MOLECULAR DIAGNOSTICS, INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
23/12/22	HTG Molecular Diagnostics Announces Closing of a $10 Million Public Offering	AQ
21/12/22	HTG Molecular Diagnostics Announces Pricing of a $10 Million Public Offering	AQ
21/12/22	HTG Announces One-for-Twelve Reverse Stock Split December 20, 2022	AQ
20/12/22	HTG Announces One-for-Twelve Reverse Stock Split	AQ
20/12/22	HTG Molecular Diagnostics : Modification to Rights of Security Holders - Form 8-K	PU
20/12/22	HTG MOLECULAR DIAGNOSTICS, INC : Material Modification to Rights of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
12/12/22	HTG Molecular Diagnostics Announces the Next Event in its RNA Profiling in Drug Discovery KOL Webcast Series	AQ
12/12/22	HTG MOLECULAR DIAGNOSTICS, INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
09/12/22	HTG Molecular Diagnostics Announces the Next Event in its RNA Profiling in Drug Discovery KOL Webcast Series	AQ